Founded in 2011, Sycamore specializes in consumer, distribution and retail companies and has raised around $ 10 billion. Among its other current and past investments are Staples, the Belk department store and the Hot Topic clothing retailer.
«Sycamore has a deep respect for the members of the talented and dedicated team of the AMB, and we are committed to administering the company’s iconic brands,» said Stefan Kaluzny, managing director of Sycamore Partners. «This transaction reflects our confidence in the model led by Pharmacy of the AMB and the essential role in promoting better results for patients, clients and communities.»
Even in the air, the future is for the assets of the Walgreens health service, led by its 53% participation in Village MD, the entity that controls the chain of the village medical clinic, as well as Summit Health and Citymd. Wentworth and his team said last year that they planned to sell at least part of that business, which ended 2024 with an adjusted Ebitda loss of $ 141 million in $ 6.4 billion in revenues, to rename Walgreens in their central pharmacy work.
The Sycamore transaction is structured to pay the Walgreens shareholders up to $ 2.7 billion of one or more MD agreements of the village if they happen and when they happen. And although executives assume that they will sell assets in certain markets this year, investors should not wait a fire sale.
In their announcement according to, Walgreens and Sycamore said that a variety of roads are coming on the table. A directors committee will add, seek to maximize the value of Walgreens in several ways, «including actions to significantly improve operational performance and strengthen the balance of companies, before any transaction or transaction of future monetization.»
